Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease.
about
Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell diseaseBiophysical markers of the peripheral vasoconstriction response to pain in sickle cell disease.Albuminuria Is Associated with Endothelial Dysfunction and Elevated Plasma Endothelin-1 in Sickle Cell Anemia.Pathophysiology and treatment of pulmonary hypertension in sickle cell diseaseHaptoglobin Preserves Vascular Nitric Oxide Signaling during HemolysisNew insights into sickle cell disease: mechanisms and investigational therapies.The heart in sickle cell disease, a model for heart failure with preserved ejection fractionIntravascular hemolysis and the pathophysiology of sickle cell disease.How we manage iron overload in sickle cell patients.Empirical model of human blood transverse relaxation at 3 T improves MRI T2 oximetry.Pathways to pulmonary hypertension in sickle cell disease: the search for prevention and early intervention.Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease.Stroke recurrence in adult sickle cell patients: it is time for action!Ready-to-use food supplement, with or without arginine and citrulline, with daily chloroquine in Tanzanian children with sickle-cell disease: a double-blind, random order crossover trial.Echocardiography Differentiates Lethally Irradiated Whole-Body From Partial-Body Exposed Rats
P2860
Q26471968-BCC08ADA-EF27-4ECA-832C-995362A4EE74Q33725104-B64FEAA0-8552-47C9-94D5-0153AB9A6A43Q36144830-4C26FD7D-98E9-45BD-B092-EA75BA4ED710Q36596861-F3A9532A-1CFA-46EA-BDFF-468EEBC93770Q36916070-9D5D8ADC-AF92-4D4C-A116-59435B083C4CQ37143296-9BC3BE2D-B4CA-4139-A4E1-BDBD9893F707Q37258454-6AEC5061-E66F-4F8C-A2B9-C96E77E69857Q39156028-4A5844F8-BB4F-4E8B-82CE-67111097DA27Q39179372-C4EE25D2-9996-4157-B86C-C34576F42F3AQ44739314-2E91C9D7-EB82-4F1A-BC9A-1BD0AC375EDEQ47799282-88A6E91E-79D5-44EF-9C40-E1568A7E24E5Q52738823-72EFE218-467F-4CE6-AB7B-393FB850DDEFQ53102076-B3D16E4F-2C27-4C70-9F4F-951BDF837D01Q55022175-4757C34E-B1BE-4221-BD9E-CAE38C360BF4Q59136387-EE1EDCBD-E5BF-43E6-894A-909FB50C25AD
P2860
Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Chronic transfusion therapy im ...... opathy in sickle cell disease.
@ast
Chronic transfusion therapy im ...... opathy in sickle cell disease.
@en
type
label
Chronic transfusion therapy im ...... opathy in sickle cell disease.
@ast
Chronic transfusion therapy im ...... opathy in sickle cell disease.
@en
prefLabel
Chronic transfusion therapy im ...... opathy in sickle cell disease.
@ast
Chronic transfusion therapy im ...... opathy in sickle cell disease.
@en
P2093
P2860
P50
P1433
P1476
Chronic transfusion therapy im ...... lopathy in sickle cell disease
@en
P2093
Herbert J Meiselman
Miklos Rabai
Roberta M Kato
P2860
P304
P356
10.1182/BLOOD-2014-12-614370
P407
P577
2015-06-02T00:00:00Z